Compare Innovative Industrial Properties Inc (IIPR) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Innovative Industrial Properties Inc vs ResMed Inc. — how do they compare? Innovative Industrial Properties Inc trades at $62.11 (market cap $1.83B), while ResMed Inc. trades at $192.97 (market cap $28.40B). The key difference: ResMed Inc. is far larger — about 15.5× Innovative Industrial Properties Inc's market cap, and Innovative Industrial Properties Inc pays the higher dividend (12.01%). Which is the better fit depends on your goals.
| IIPR | RMD | |
|---|---|---|
Market Cap | $1.83B | $28.40B |
Sector | Real Estate | Health |
52-Week High | $64.67 | $293.73 |
52-Week Low | $44.58 | $182.82 |
Enterprise Value | $2.22B | $27.58B |
Dividend Yield | 12.01% | 1.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IIPR trades at $63.25, down 1.89% today, with a bullish technical signal from moving averages. The REIT shows strong profitability with 88.46% gross margins and 45.58% net income margin, though revenue declined to $266M in 2025. Recent news highlights successful debt refinancing and upcoming Q2 2026 earnings on August 3rd, with analyst consensus leaning Hold (54.55%).
The outlook remains cautious due to revenue declines and mixed earnings performance, but strong margins and recent capital structure improvements provide stability. Key risks include cannabis sector volatility and tenant credit quality, while the 9% dividend yield offers income appeal. Wall Street sentiment is neutral with balanced risk-reward.
ResMed (RMD) trades at $195.8, down 1.6% on the day, with a bearish technical signal but strong fundamentals. Recent quarterly earnings have consistently beaten estimates, with Q1 2026 EPS of $2.86 exceeding the $2.80 forecast. The company sold its MatrixCare business for $490 million in July 2026 to sharpen focus on connected care, signaling strategic refinement. Revenue growth remains robust, climbing to $5.15 billion in 2025, with net income margins expanding to 27.44%.
The outlook is supported by solid earnings momentum and a consensus price target of $245.88, implying 25.6% upside. Risks include competitive pressures in medical equipment and reliance on sleep apnea market growth. Analyst sentiment is mixed with 40% buy ratings, but institutional selling by Baader Bank in Q1 2026 warrants monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Innovative Industrial Properties Inc
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
